TechMARK movers: Renovo on course for trial results in 2011

Shares in scar reduction treatments developer Renovo have fallen even though it has reaffirmed that the main treatment Juvista is on course to complete its first European phase III trial, covering scar revision surgery, in the first half of 2011. Renovo

Leave a Reply